MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Cash Flow Overview

Change in Cash
-$43K
Free Cash flow
$13K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Initial fair value of true-up co...
    • Change in fair value of converti...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Cost of goods sold
    • General and administrative expen...
    • Sales expense
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product sales, net
2,985
3,195
3,307
3,256
Cost of goods sold
1,535
1,633
1,636
1,677
Gross profit
1,450
1,562
1,671
1,579
Research and development expense
18
18
18
24
Sales expense
644
673
663
691
Marketing expense
381
401
418
429
General and administrative expense
708
788
647
710
Benefit from reversal of accrued payroll taxes
0
0
0
0
Total operating expenses
1,751
1,880
1,746
1,854
Operating loss
-301
-318
-75
-275
Gain on extinguishment of debt
0
20
-
0
Loss on debt conversions
-249
-
-
-
Change in fair value of convertible notes
219
-
-
-
Interest expense, net
1
93
-
-
Total other expense
794
-
-91
-107
Loss before income taxes
-770
-643
-204
-382
Income tax expense
5
0
2
0
Net loss
-775
-643
-206
-382
Depreciation and amortization
22
23
21
31
Stock-based compensation
148
148
123
124
Amortization of debt discount
0
91
127
107
Loss on debt conversion
-26
-
-
-
Initial fair value of true-up convertible notes issued
-223
-
-
-
Gain in fair value of contingent consideration liabilities
-
-
0
0
Fair value adjustment for convertible notes payable
-
-252
-
-
Change in fair value of convertible notes
219
252
-
-
Gain on debt extinguishment
0
20
0
0
Amortization of right of use assets
66
65
63
63
Benefit from reversal of accrued payroll tax (note 12)
0
0
0
0
Deferred taxes
-
-
-3
-
Other
0
-12
10
23
Accounts receivable, net
-44
-22
6
-142
Inventory
64
-174
3
-132
Prepaid expenses and other
-92
28
-25
-64
Accounts payable and accrued expenses
85
92
-266
-563
Operating lease liabilities
-66
-63
-245
-
Net cash flows provided by operating activities
20
101
-307
-306
Purchases of property and equipment
7
3
9
11
Acquisition of business, net of cash acquired
-
-
0
0
Net cash flows used in investing activities
-7
-3
-9
-11
Proceeds from note payable
0
0
450
0
Debt issuance costs related to note payable
0
15
8
0
Repayment of note payable
0
0
150
214
Repayment of unsecured debt
54
53
34
20
Net cash flows provided by (used in) financing activities
-54
-68
258
-234
Effect of exchange rate changes on cash
-2
1
2
-1
Net decrease in cash
-43
31
-103
-505
Cash, beginning of period
309
278
381
454
Cash, end of period
266
309
278
381
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

CVSI Cash Flow Sankey DiagramSankey diagram visualizing CVSI cash flow for the periodInitial fair value oftrue-up convertible...-$223K Change in fair value ofconvertible notes$219K Stock-based compensation$148K (-40.80%↓ Y/Y)Prepaid expenses andother-$92K (-19.48%↓ Y/Y)Accounts payable andaccrued expenses$85K (116.57%↑ Y/Y)Amortization of right of useassets$66K (-41.07%↓ Y/Y)Accounts receivable, net-$44K (-466.67%↓ Y/Y)Loss on debtconversion-$26K Depreciation andamortization$22K (-84.29%↓ Y/Y)Net cash flowsprovided by operating...$20K (-90.29%↓ Y/Y)Canceled cashflow$905K Net decrease in cash-$43K (-109.95%↓ Y/Y)Canceled cashflow$20K Net loss-$775K (-109.46%↓ Y/Y)Operating leaseliabilities-$66K Inventory$64K (109.17%↑ Y/Y)something is missing$325K Product sales, net$2,985K (-58.69%↓ Y/Y)Net cash flowsprovided by (used in)...-$54K (-117.25%↓ Y/Y)Net cash flows usedin investing...-$7K (92.13%↑ Y/Y)Effect of exchange ratechanges on cash-$2K (-200.00%↓ Y/Y)Loss before incometaxes-$770K (-112.12%↓ Y/Y)Income tax expense$5K (-28.57%↓ Y/Y)Canceled cashflow$325K Gross profit$1,450K (-58.60%↓ Y/Y)Canceled cashflow$1,535K Repayment of unsecureddebt$54K (-54.62%↓ Y/Y)Purchases of property andequipment$7K (-92.13%↓ Y/Y)Total other expense$794K (382.56%↑ Y/Y)Operating loss-$301K (-150.83%↓ Y/Y)Canceled cashflow$1,450K Cost of goods sold$1,535K (-58.78%↓ Y/Y)something is missing$325K Loss on debtconversions-$249K Change in fair value ofconvertible notes$219K Interest expense, net$1K Total operatingexpenses$1,751K (-51.66%↓ Y/Y)General andadministrative expense$708K (-60.58%↓ Y/Y)Sales expense$644K (-55.56%↓ Y/Y)Marketing expense$381K (-53.48%↓ Y/Y)Research and developmentexpense$18K (-77.50%↓ Y/Y)

CV Sciences, Inc. (CVSI)

CV Sciences, Inc. (CVSI)